Xylem (XYL) Misses Q2 EPS by 2c, Beats on Revenues; Raises FY17 EPS / Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/1/2026
- Wall St futures gain as AI, consulting stocks offset bond-market jitters
- Oil prices rise 2% as China suspends fuel exports
- Amazon and these four U.S. stocks are latest additions to Goldman’s flagship list
- Elevated equity positioning, leverage could challenge stocks in Q4: JPMorgan
- These 5 AI chip stocks are must-own into Q4, BofA says
- Zimbabwe helicopter crash kills six, government spokesperson says
- Apple's iOS 27 is blocking Trade Desk ads on Safari, analyst says
- S&P 500 dips, Nasdaq higher after data shows moderate inflation rise
- DataMeds AI's Corexa Pharmacy tops $1M in monthly revenue
- Mattel names Roger Lynch as chairman and CEO, replacing Ynon Kreiz
Xylem (XYL) PT Raised to $66 at Oppenheimer Following 2Q EPS Beat
August 2, 2017 9:41 AM EDTOppenheimer raised its price target on Xylem (NYSE: XYL) to $66.00 (from $60.00) while maintaining a Outperform rating following the company's 2Q. XYL reported adjusted EPS of $0.59, above consensus estimates for 0.57.
Analyst Jim Giannakouros believes that the company remains well positioned for sustainable... More
